ATTORNEY-CLIENT PRIVILEGED AND CONFIDENTIAL ATTORNEY WORK PRODUCT DO NOT DISTRIBUTE OUTSIDE THE DEAL TEAM WITHOUT PRIOR AUTHORIZATION FROM THE AUTHORS
This memorandum is protected by the attorney-client privilege and constitutes attorney work product prepared in anticipation of litigation and/or in connection with the provision of legal advice. This memorandum is intended solely for the use of the addressees and authorized recipients identified herein. Any unauthorized disclosure, distribution, copying, or use of this memorandum or the information contained herein is strictly prohibited. If you have received this memorandum in error, please notify the authors immediately and destroy all copies.
CALDERWOOD & HARKNESS LLP 1750 K Street NW, Suite 800 Washington, DC 20006
June 14, 2023
MEMORANDUM
FROM: Margaret "Peggy" Ashworth, Of Counsel, National Security & CFIUS Practice Group, Calderwood & Harkness LLP, 1750 K Street NW, Suite 800, Washington, DC 20006
Lt. Col. (Ret.) David Caruso, Senior Counsel, Government Contracts & Export Controls Practice Group, Calderwood & Harkness LLP, 1750 K Street NW, Suite 800, Washington, DC 20006
TO: Beatrice Holloway, Responsible Partner, Mergers & Acquisitions Practice Group, Calderwood & Harkness LLP, 399 Park Avenue, 31st Floor, New York, NY 10022
CC: James Prentice, Billing Partner, M&A Practice Group, Calderwood & Harkness LLP Priya Venkataraman, Associate, International Trade & Sanctions Practice Group, Calderwood & Harkness LLP Kenneth Morales, Associate, Corporate/M&A Practice Group, Calderwood & Harkness LLP
RE: CFIUS Jurisdictional Analysis — Proposed Acquisition of Marlowe Asset Management Photonics Inc. by Halcyon Semiconductor Aktiengesellschaft
MATTER NO.: 1032-00004
ATTORNEY-CLIENT PRIVILEGED AND CONFIDENTIAL — ATTORNEY WORK PRODUCT — DO NOT DISTRIBUTE
Right-click to update Table of Contents
I. Executive Summary
The purpose of this memorandum is to analyze whether the proposed acquisition of 100% of the outstanding equity of Marlowe Asset Management Photonics Inc. ("VPI"), a Delaware C-corporation headquartered in Colorado Springs, Colorado, by Halcyon Semiconductor Aktiengesellschaft ("HSAG"), a publicly traded German Aktiengesellschaft headquartered in Dresden, Saxony, Germany, constitutes a "covered transaction" subject to review by the Committee on Foreign Investment in the United States ("CFIUS") under Section 721 of the Defense Production Act of 1950, as amended (50 U.S.C. § 4565) (the "DPA"), and its implementing regulations at 31 C.F.R. Part 800 (the "Regulations"). This memorandum also addresses whether the transaction triggers a mandatory filing obligation under the Foreign Investment Risk Review Modernization Act of 2018 ("FIRRMA") and the mandatory declaration provisions set forth at 31 C.F.R. § 800.401.
Conclusion. Based on our analysis of the transaction structure, the parties, and VPI's business activities, products, and government relationships, we conclude as follows:
The proposed transaction is a covered transaction under 31 C.F.R. § 800.213(a)(1). The transaction would result in a foreign person (HSAG, acting through its wholly owned acquisition vehicle, Halcyon US Holdings Inc.) obtaining control of a U.S. business (VPI) within the meaning of the statute and Regulations.
Moreover, VPI qualifies as a "TID U.S. business" engaged in "critical technologies" as defined in 31 C.F.R. §§ 800.248 and 800.215. Specifically, VPI produces, designs, manufactures, and develops items that are controlled under both the International Traffic in Arms Regulations ("ITAR"), 22 C.F.R. Parts 120–130 (as defense articles classified under ITAR Category XI(a)(3) of the United States Munitions List), and the Export Administration Regulations ("EAR"), 15 C.F.R. Parts 730–774 (as items classified under ECCN 3A001 and ECCN 3E001 on the Commerce Control List). This TID status triggers a mandatory filing obligation under 31 C.F.R. § 800.401.
We recommend that the parties file a full voluntary joint notice under 31 C.F.R. § 800.501 rather than the short-form mandatory declaration under § 800.401(a). The strategic considerations supporting this recommendation are detailed in a separate memorandum currently in preparation; however, in summary, the complexity and national security sensitivity of VPI's classified programs, the breadth of its export-controlled product portfolio, and the virtual certainty that CFIUS will initiate a full investigation and negotiate a National Security Agreement ("NSA") all strongly favor the submission of a comprehensive notice over a truncated declaration.
Key risk factors identified in this analysis include the following:
•  VPI holds classified Department of Defense contracts at up to the SECRET level, with an aggregate contract backlog of approximately $193 million across 14 active prime contracts and subcontracts.
•  VPI designs and manufactures ITAR Category XI(a)(3) defense articles (GaN power amplifier components for military radar, missile defense, and satellite communications systems) and EAR ECCN 3A001 dual-use semiconductor components (GaN power amplifiers for 5G infrastructure and commercial satellite communications).
•  VPI employs 212 personnel with active U.S. government security clearances (out of a total workforce of 486 employees, or approximately 43.6%).
•  VPI maintains a Facility Security Clearance ("FCL") at the SECRET level at its 45,000-square-foot GaN-on-SiC fabrication facility in Albuquerque, New Mexico.
•  The acquisition by HSAG will create a Foreign Ownership, Control, or Influence ("FOCI") condition under the National Industrial Security Program Operating Manual ("NISPOM"), 32 C.F.R. Part 117, necessitating a FOCI mitigation instrument (most likely incorporated within the terms of a CFIUS-negotiated NSA).
Filing must be made before closing. Under the mandatory declaration provisions of 31 C.F.R. § 800.401(a), parties must submit a filing at least 30 days before the expected completion date of the transaction. The acquisition cannot close without CFIUS clearance or safe harbor. The Stock Purchase Agreement ("SPA"), executed June 10, 2023, is expected to contain a closing condition requiring receipt of CFIUS clearance or expiration of the applicable waiting period.
II. Transaction Overview
A. The Parties
1. The Acquiror — Halcyon Semiconductor AG
Halcyon Semiconductor Aktiengesellschaft ("HSAG") is the ultimate acquiring party in the proposed transaction. The following summarizes the key corporate and business information relevant to the CFIUS jurisdictional analysis.
Corporate Information:
•  Full Legal Name: Halcyon Semiconductor Aktiengesellschaft
•  Entity Type: Aktiengesellschaft (public stock corporation) organized under the laws of the Federal Republic of Germany
•  Jurisdiction of Organization: Germany (Free State of Saxony)
•  Commercial Register: Amtsgericht Dresden, HRB 28416
•  Stock Exchange Listing: Frankfurt Stock Exchange (XETRA ticker: HLC)
•  Legal Entity Identifier (LEI): 5299007KXQ2M4GHILZ38
•  Headquarters: Industriestraße 44, 01099 Dresden, Saxony, Germany
•  Market Capitalization (as of June 1, 2023): approximately €14.8 billion
•  FY2022 Revenue: €6.12 billion
•  FY2022 EBITDA: €1.37 billion
Key Officers:
•  Chief Executive Officer (Vorstandsvorsitzender): Dr. Maximilian Ehrhardt (German citizen; no U.S. security clearance)
•  Chief Financial Officer: Katarina Brückner (German citizen; no U.S. security clearance)
•  General Counsel: Stefan Lohse, LL.M. (Georgetown University Law Center); admitted to the bar in New York and in Germany (Rechtsanwalt); German/U.S. dual citizen
HSAG is a leading European semiconductor company specializing in power semiconductors, sensors, and microcontroller solutions for automotive, industrial, and defense applications. HSAG's business is diversified across multiple end markets, with significant revenue derived from the European automotive sector and industrial power management applications.
CFIUS Classification: HSAG is a "foreign person" under 31 C.F.R. § 800.224. As an entity organized under the laws of Germany, HSAG qualifies as a foreign person regardless of any U.S. connections maintained by its officers (such as Mr. Lohse's dual citizenship and New York bar admission). The determinative factor under the Regulations is HSAG's status as a non-U.S. entity organized under foreign law.
Government Ownership and Control: Based on our review of HSAG's publicly available shareholder disclosures and the corporate information provided by HSAG's German counsel (Schilling Frey Rechtsanwälte), we have not identified any ownership or control interest held by the German federal government, any German state (Land) government, or any other foreign government in HSAG. HSAG is a widely held public company listed on the Frankfurt Stock Exchange. While we note that certain German state-affiliated pension funds and sovereign-adjacent investment vehicles may hold de minimis positions in HSAG's publicly traded shares, no such investor has been identified as holding a material ownership stake or exercising any degree of control over HSAG's operations or governance.
Existing U.S. Operations: HSAG maintains an existing U.S. subsidiary:
•  Entity: Halcyon US Inc.
•  Entity Type: Delaware C-corporation
•  EIN: 81-3056429
•  Address: 11501 Alterra Parkway, Suite 300, Austin, TX 78758
•  Employees: Approximately 320
•  Operations: Fabless semiconductor design center focused on power management ICs for automotive applications
•  Security Posture: No classified work, no ITAR registrations, no EAR Part 744 restricted activities, no facility security clearance
Halcyon US Inc. does not perform any defense-related work, hold any facility security clearances, or maintain any registrations with the Directorate of Defense Trade Controls ("DDTC"). Its operations are entirely commercial in nature. The existence of Halcyon US Inc. does not alter the CFIUS jurisdictional analysis; however, CFIUS may consider HSAG's existing U.S. footprint as part of its national security risk assessment.
2. The Acquisition Vehicle — Halcyon US Holdings Inc.
HSAG has formed a special-purpose acquisition vehicle for the purpose of consummating the proposed transaction.
•  Full Legal Name: Halcyon US Holdings Inc.
•  Entity Type: Delaware C-corporation
•  Date of Formation: June 5, 2023
•  EIN: 93-2841067
•  Registered Agent: National Registered Agents of Delaware, 160 Greentree Drive, Suite 101, Dover, DE 19904
•  Ownership: Wholly owned subsidiary of HSAG
•  Purpose: Formed specifically as the acquisition vehicle for the VPI transaction; no prior operations, assets, liabilities, or employees
Halcyon US Holdings Inc. is itself a "foreign person" under 31 C.F.R. § 800.224 because it is controlled by HSAG, a foreign entity. Under the Regulations, an entity over which control is exercised by a foreign person is itself considered a foreign person. See 31 C.F.R. § 800.224(b). The interposition of Halcyon US Holdings Inc. as a U.S.-incorporated acquisition vehicle between HSAG and VPI does not affect the jurisdictional analysis or eliminate the foreign character of the acquiring party for CFIUS purposes. This is a well-established principle in CFIUS practice and has been consistently applied by the Committee.
3. The Target — Marlowe Asset Management Photonics Inc.
Marlowe Asset Management Photonics Inc. ("VPI") is the U.S. business that is the target of the proposed acquisition. VPI is a specialty semiconductor company focused on the design, development, and manufacture of gallium nitride (GaN) power amplifier components for defense, aerospace, and commercial telecommunications applications.
Corporate Information:
•  Full Legal Name: Marlowe Asset Management Photonics Inc.
•  Entity Type: Delaware C-corporation
•  Date of Incorporation: February 14, 2009
•  EIN: 26-4371885
•  Headquarters: 7400 Ridgeline Parkway, Colorado Springs, CO 80919
•  Fabrication Facility: 9200 Innovation Boulevard, Albuquerque, NM 87113 (45,000-square-foot GaN-on-SiC fabrication facility)
Key Officers:
•  Founder & Chief Executive Officer: Dr. Nathan Trevorrow (holds TS/SCI clearance)
•  President & Chief Operating Officer: Marissa Sung-Avila (holds SECRET clearance)
•  Chief Financial Officer: Derek Wainsborough (no security clearance)
•  Vice President, Government Programs & Facility Security Officer ("FSO"): Col. (Ret.) Bryce Hendrickson, USAF (holds TS/SCI clearance)
Financial Information:
•  FY2022 Revenue: $287.4 million
•  FY2022 EBITDA: $61.2 million
Workforce and Security Clearances:
•  Total Employees: 486
•  Employees with Active U.S. Government Security Clearances: 212 (approximately 43.6% of total workforce)
•  Clearance levels held by VPI personnel range from CONFIDENTIAL through TOP SECRET/SCI
CFIUS Classification: VPI is a "U.S. business" under 31 C.F.R. § 800.252. VPI is an entity incorporated in the State of Delaware, headquartered in Colorado Springs, Colorado, with manufacturing operations in Albuquerque, New Mexico. VPI is engaged in interstate commerce in the United States through its design, manufacture, and sale of semiconductor components to customers throughout the United States, including the U.S. Department of Defense and its prime contractors. VPI clearly satisfies the definition of a U.S. business under the Regulations.
VPI's business is further described in Sections V, VII, and VIII of this memorandum in connection with the analyses of critical technologies, facility security clearances, and government contracts.
4. Existing VPI Shareholders (Sellers)
All of VPI's outstanding equity is currently held by U.S. persons. The table below summarizes VPI's existing ownership structure as reflected in VPI's capitalization table provided in connection with the SPA:
Ridgecrest Ventures Fund III, L.P. is a Delaware limited partnership. Its general partner is Ridgecrest Ventures Management LLC. The principal of Ridgecrest Ventures Management LLC is Franklin Yee, Managing Partner. Address: 3300 Sand Hill Road, Suite 220, Menlo Park, CA 94025. Ridgecrest Ventures Fund III, L.P. is a U.S. venture capital fund with no foreign person investors or general partners that we have identified based on information currently available.
Cascadian Capital Partners Growth Fund II, L.P. is a Delaware limited partnership. Its general partner is Cascadian Capital Partners Management LLC. The principal of Cascadian Capital Partners Management LLC is Olivia Hartmann, Managing Director. Address: 1201 Third Avenue, Suite 4400, Seattle, WA 98101. Cascadian Capital Partners Growth Fund II, L.P. is a U.S. growth equity fund with no foreign person investors or general partners that we have identified based on information currently available.
All sellers are U.S. persons. No foreign person currently holds any equity interest in VPI, whether directly or indirectly. This fact simplifies the CFIUS analysis insofar as there is no pre-existing foreign ownership or control of VPI, and the proposed transaction represents the initial introduction of foreign ownership and control.
B. Transaction Structure and Key Terms
The proposed transaction is structured as a 100% stock acquisition in which Halcyon US Holdings Inc. will acquire all of the outstanding equity interests in VPI from VPI's existing shareholders. The key commercial terms of the transaction, as set forth in the Stock Purchase Agreement ("SPA") executed on June 10, 2023, are summarized below.
Purchase Price and Consideration:
•  Purchase Price: $1,420,000,000 (one billion four hundred twenty million dollars), calculated on a cash-free, debt-free basis with a normalized net working capital target of $34.6 million (per SPA § 2.5)
•  Form of Consideration: 100% cash payable at closing
•  Escrow Holdback: $71,000,000 (5% of purchase price), to be held for 18 months post-closing for the satisfaction of indemnification claims under the SPA
•  Escrow Agent: Pinnacle Trust Company, N.A., 400 South LaSalle Street, Suite 1100, Chicago, IL 60605
•  Earnout: Up to $85,000,000 in aggregate contingent consideration, payable in two tranches:
•  $50,000,000 if VPI achieves specified government-contract revenue milestones in calendar year 2024
•  $35,000,000 if VPI achieves specified government-contract revenue milestones in calendar year 2025
•  Maximum Aggregate Consideration: $1,505,000,000 (including base purchase price and maximum earnout)
Financing:
•  Debt Financing: $900 million senior secured term loan from a lending syndicate led by Meridian National Bank (as administrative agent), with Atlas Commercial Lending AG and Pacific Basin Credit Corp. serving as co-lead arrangers
•  Equity Contribution: $520 million from HSAG, funded from balance sheet cash reserves and a €300 million draw on HSAG's existing revolving credit facility with Rheinische Handelsbank AG
Representation and Warranty Insurance:
•  Insurer: Graystone Specialty Insurance Company
•  Policy Limit: $142,000,000
•  Retention: $14,200,000
•  Premium: $4,970,000
•  Policy Number: GSI-RW-2023-04821
Post-Closing Ownership Structure:
Following the closing of the transaction, HSAG (through its wholly owned subsidiary, Halcyon US Holdings Inc.) will own 100% of the outstanding equity of VPI. This will result in complete foreign ownership of VPI by a German Aktiengesellschaft. The resulting ownership structure is as follows:
HSAG (Germany) → Halcyon US Holdings Inc. (Delaware) → Marlowe Asset Management Photonics Inc. (Delaware)
This ownership structure will create a Foreign Ownership, Control, or Influence condition for VPI's facility security clearance, as discussed in Section VII below.
C. Counsel
The following law firms and attorneys are representing the parties in connection with the proposed transaction:
HSAG's U.S. Counsel:
•  Calderwood & Harkness LLP
•  Beatrice Holloway, Partner — Mergers & Acquisitions (lead deal counsel)
•  Margaret "Peggy" Ashworth, Of Counsel — National Security & CFIUS (CFIUS lead)
•  Lt. Col. (Ret.) David Caruso, Senior Counsel — Government Contracts & Export Controls (government contracts and export controls lead)
HSAG's German Counsel:
•  Schilling Frey Rechtsanwälte
•  Prof. Dr. Ulrich Schilling (lead German counsel)
VPI/Sellers' Counsel:
•  Wethersfield & Gale LLP
•  Harrison Whitfield, Partner — Government Contracts & National Security
•  Sandra Niehaus, Partner — Mergers & Acquisitions
We note that Wethersfield & Gale has retained Harrison Whitfield specifically for the CFIUS and government contracts workstreams. Mr. Whitfield is well known in the CFIUS bar and has extensive experience representing targets and sellers in transactions involving classified defense contractors. We anticipate productive coordination with Mr. Whitfield's team on the preparation and submission of the joint CFIUS notice.
III. Statutory and Regulatory Framework
This section provides an overview of the statutory and regulatory framework governing CFIUS review of foreign investment transactions. This framework establishes the jurisdictional predicates that determine whether the proposed transaction is subject to CFIUS review and, if so, whether a mandatory filing obligation is triggered.
A. Section 721 of the Defense Production Act
The principal statutory authority for CFIUS review of foreign investment transactions is Section 721 of the Defense Production Act of 1950, as amended ("Section 721"), codified at 50 U.S.C. § 4565. Section 721 authorizes the President, acting through CFIUS, to review "covered transactions" to determine the effects of such transactions on the national security of the United States, and to take action to suspend or prohibit any covered transaction that threatens to impair the national security.
Section 721 was substantially amended by the Foreign Investment Risk Review Modernization Act of 2018 ("FIRRMA"), enacted as Subtitle A of Title XVII of the John S. McCain National Defense Authorization Act for Fiscal Year 2019, Public Law 115-232. FIRRMA expanded the scope of CFIUS jurisdiction in several significant respects, including by:
(a) Expanding CFIUS's authority to review certain non-controlling foreign investments in U.S. businesses that deal in critical technologies, critical infrastructure, or sensitive personal data (so-called "TID U.S. businesses");
(b) Establishing a mandatory filing requirement for certain transactions involving critical technologies, where previously all CFIUS filings were voluntary;
(c) Expanding CFIUS jurisdiction to review certain real estate transactions involving foreign persons near military installations and other sensitive government facilities; and
(d) Providing the Committee with additional tools and timelines for conducting reviews and investigations.
CFIUS Composition. CFIUS is an interagency committee established by executive order and chaired by the Secretary of the Treasury (acting through the Department of the Treasury's Office of Investment Security ("OIS")). The voting members of CFIUS include the heads (or their designees) of the following departments and agencies:
•  Department of the Treasury (Chair)
•  Department of Defense
•  Department of State
•  Department of Commerce
•  Department of Homeland Security
•  Department of Energy
•  Department of Justice (Attorney General)
•  Office of Science and Technology Policy
•  Office of the U.S. Trade Representative
Additional agencies may participate in specific reviews depending on the subject matter of the transaction. The Director of National intelligence and the Secretary of Labor serve as non-voting, ex officio members.
Anticipated Co-Lead Agencies. For the proposed transaction, we anticipate that the Department of Defense and the Department of Energy will serve as co-lead agencies alongside Treasury in the CFIUS review. The Department of Defense's involvement is expected given VPI's extensive classified DoD contract portfolio, its production of ITAR-controlled defense articles for military radar and missile defense applications, and the facility security clearance maintained at VPI's Albuquerque fabrication facility. The Department of Energy's involvement is anticipated because VPI's GaN-on-SiC semiconductor technology has applications in areas within the Department of Energy's purview, including advanced materials science and dual-use energy infrastructure. The Department of Commerce (Bureau of Industry and Security) may also play an active role given VPI's EAR-controlled product lines.
B. Implementing Regulations — 31 C.F.R. Part 800
The implementing regulations for Section 721 are set forth in 31 C.F.R. Part 800, which governs "covered control transactions" (transactions that could result in foreign control of a U.S. business) and certain "covered investments" (non-controlling investments in TID U.S. businesses that afford the foreign investor specified access, rights, or involvement). Part 800 was comprehensively revised effective February 13, 2020, to implement the FIRRMA amendments.
A separate set of regulations at 31 C.F.R. Part 802 governs certain real estate transactions involving foreign persons near sensitive government facilities. Part 802 is not implicated by the proposed transaction, as the transaction involves the acquisition of a U.S. business rather than a real estate transaction within the scope of Part 802.
The following key regulatory definitions are central to the jurisdictional analysis set forth in Sections IV and V below:
•  "Covered transaction" (31 C.F.R. § 800.213) — a transaction by or with any foreign person that could result in foreign control of any U.S. business, or certain non-controlling investments in TID U.S. businesses, subject to specified exceptions.
•  "Foreign person" (31 C.F.R. § 800.224) — any foreign national, foreign government, or entity organized under the laws of a foreign state, or any entity over which control is exercised or exercisable by a foreign national, foreign government, or entity organized under foreign law.
•  "U.S. business" (31 C.F.R. § 800.252) — any entity, irrespective of the nationality of the persons that control it, engaged in interstate commerce in the United States, but only to the extent of its activities in interstate commerce.
•  "Control" (31 C.F.R. § 800.208) — the power, direct or indirect, whether or not exercised, to determine, direct, or decide important matters affecting an entity, including through ownership of a majority or dominant minority of the outstanding voting interest; board representation; proxy voting; contractual arrangements; or other means.
•  "TID U.S. business" (31 C.F.R. § 800.248) — a U.S. business that (i) produces, designs, tests, manufactures, fabricates, or develops one or more "critical technologies"; (ii) performs certain functions with respect to covered investment "critical infrastructure"; or (iii) maintains or collects certain categories of "sensitive personal data" of U.S. citizens.
•  "Critical technologies" (31 C.F.R. § 800.215) — defined to include, among other categories, defense articles and defense services on the United States Munitions List (USML), items on the Commerce Control List (CCL) controlled for specified reasons, and emerging and foundational technologies controlled under the Export Control Reform Act of 2018.
Each of these definitions is applied to the facts of the proposed transaction in the analysis sections below.
C. FIRRMA Amendments and Mandatory Filing Provisions
One of the most significant changes introduced by FIRRMA is the establishment of a mandatory filing obligation for certain transactions involving critical technologies. Prior to FIRRMA, all CFIUS filings were voluntary, although the Committee retained the authority to initiate reviews of non-notified transactions on its own initiative. FIRRMA introduced a mandatory requirement that parties file with CFIUS before completing certain transactions involving critical technologies, thereby ensuring that the Committee has the opportunity to review such transactions before the foreign person obtains control of, or makes a covered investment in, a TID U.S. business.
The mandatory filing provision is codified at 31 C.F.R. § 800.401 and provides that parties to a covered transaction must submit a declaration (a short-form filing of no more than five pages, plus attachments) to CFIUS at least 30 days before the expected completion date of the transaction in the following circumstances:
(a) The transaction is a covered transaction involving a TID U.S. business that produces, designs, tests, manufactures, fabricates, or develops one or more critical technologies; and
(b) A U.S. regulatory authorization (i.e., an export license or other authorization under the ITAR, EAR, or other applicable export control regime) would be required for the export, reexport, or transfer (in-country) of the critical technology to the foreign person that is a party to the transaction, or to any person that holds a direct or indirect interest in the foreign person (i.e., the foreign person's relevant shareholders).
Importantly, the mandatory filing obligation may be satisfied by submitting either a short-form declaration under § 800.403 or a full voluntary joint notice under § 800.501. The filing of a voluntary joint notice is deemed to satisfy the mandatory declaration requirement. See 31 C.F.R. § 800.401(f). Upon receipt of a declaration, CFIUS has 30 assessment days to take one of several actions, including requesting a full notice, initiating a unilateral review, informing the parties that CFIUS cannot conclude action on the basis of the declaration, or notifying the parties that CFIUS has concluded that there are no unresolved national security concerns. Given the complexity of the present transaction, we strongly anticipate that a short-form declaration would result in CFIUS requesting a full notice, thereby adding unnecessary delay to the process, as discussed further in Section VI.B below.
The application of the mandatory filing provisions to the proposed transaction is analyzed in detail in Section VI.
IV. Analysis — Covered Transaction
This section applies the statutory and regulatory framework summarized above to the facts of the proposed transaction in order to determine whether the transaction constitutes a "covered transaction" subject to CFIUS jurisdiction under 31 C.F.R. § 800.213. The analysis proceeds in three steps: (A) determining whether VPI qualifies as a "U.S. business"; (B) determining whether HSAG qualifies as a "foreign person"; and (C) determining whether the transaction would result in HSAG acquiring "control" of VPI.
A. VPI as a "U.S. Business" (31 C.F.R. § 800.252)
Under 31 C.F.R. § 800.252, a "U.S. business" is defined as "any entity, irrespective of the nationality of the persons that control it, engaged in interstate commerce in the United States, but only to the extent of its activities in interstate commerce." The definition is intentionally broad and encompasses virtually any entity that conducts business activities within the United States.
VPI satisfies this definition without question. VPI is a Delaware C-corporation that was incorporated on February 14, 2009, and has continuously maintained its corporate existence and conducted business operations in the United States since that date. VPI is headquartered in Colorado Springs, Colorado, and operates a 45,000-square-foot GaN-on-SiC semiconductor fabrication facility in Albuquerque, New Mexico. VPI employs 486 persons in the United States and generated $287.4 million in revenue in fiscal year 2022 from the sale of semiconductor components to customers throughout the United States and, through authorized exports, to allied foreign governments.
VPI's business activities are quintessentially "interstate commerce" — VPI designs semiconductor products at its Colorado Springs headquarters, fabricates those products at its Albuquerque, New Mexico facility, and sells and delivers finished products to customers located in multiple states, including prime defense contractors, the U.S. Department of Defense, and commercial telecommunications companies. VPI's 14 active DoD contracts involve the production and delivery of defense articles across state lines to multiple U.S. government and contractor facilities.
Conclusion: VPI clearly qualifies as a "U.S. business" under 31 C.F.R. § 800.252.
B. HSAG as a "Foreign Person" (31 C.F.R. § 800.224)
Under 31 C.F.R. § 800.224, a "foreign person" means:
(a) Any foreign national;
(b) Any foreign government;
(c) Any entity organized under the laws of a foreign state; or
(d) Any entity over which control is exercised or exercisable by a foreign national, foreign government, or entity organized under the laws of a foreign state.
HSAG is an Aktiengesellschaft organized under the laws of the Federal Republic of Germany, with its registered office in Dresden, Saxony. HSAG's shares are publicly traded on the Frankfurt Stock Exchange. HSAG is headquartered in Germany, governed by German corporate law, and managed by German citizens. HSAG is, without question, "an entity organized under the laws of a foreign state" within the meaning of § 800.224(c).
Halcyon US Holdings Inc., the acquisition vehicle formed as a Delaware C-corporation on June 5, 2023, is likewise a "foreign person" under § 800.224(d). Although Halcyon US Holdings is organized under the laws of the State of Delaware, it is wholly owned and controlled by HSAG, a foreign entity. Under the Regulations, an entity "over which control is exercised or exercisable by" a foreign person is itself classified as a foreign person. HSAG's 100% ownership of Halcyon US Holdings conclusively establishes the requisite control. The use of a U.S.-incorporated acquisition vehicle does not shield the transaction from CFIUS jurisdiction or alter the foreign character of the acquiring party.
We note that no foreign government ownership or control interest has been identified in HSAG's shareholder base. HSAG is a widely held public company, and our review of HSAG's shareholder disclosures and registrations with the German Federal Financial Supervisory Authority (BaFin) has not revealed any ownership interest by the German federal government, any German state government, or any foreign government entity. While the absence of foreign government ownership or control is relevant to CFIUS's risk assessment (as government-controlled transactions may raise heightened concerns), it does not affect the threshold jurisdictional question of whether HSAG is a "foreign person."
Conclusion: HSAG is a "foreign person" under 31 C.F.R. § 800.224(c). Halcyon US Holdings Inc. is also a "foreign person" under § 800.224(d).
C. "Control" (31 C.F.R. § 800.208)
Under 31 C.F.R. § 800.208, "control" means "the power, direct or indirect, whether or not exercised, to determine, direct, or decide important matters affecting an entity." The regulation provides a non-exhaustive list of factors that may establish control, including:
(i) Ownership of a majority or dominant minority of the outstanding voting interest in an entity;
(ii) Board representation;
(iii) Proxy voting;
(iv) A special share or contractual arrangement, including a shareholders' agreement, management agreement, or similar arrangement, that conveys the power to determine, direct, or decide important matters affecting an entity;
(v) Other means.
The regulation further specifies that "important matters" include, but are not limited to: the sale, lease, mortgage, pledge, or other transfer of any of the tangible or intangible principal assets of the entity; the reorganization, merger, or dissolution of the entity; the closing, relocation, or substantial alteration of the production, operational, or research and development facilities of the entity; major expenditures and investments; the issuance, sale, or retirement of equity; the appointment or dismissal of officers, directors, and other senior management; and the entry into, amendment, or termination of significant contracts.
In the proposed transaction, HSAG will acquire 100% of the outstanding equity of VPI through its wholly owned subsidiary, Halcyon US Holdings Inc. This is the paradigmatic case of a control acquisition. Post-closing, HSAG (through Halcyon US Holdings) will have the unilateral power to:
•  Appoint and remove all members of VPI's board of directors;
•  Appoint and dismiss all of VPI's officers, including the CEO, COO, CFO, and FSO;
•  Approve VPI's annual budget, capital expenditure plans, and strategic direction;
•  Authorize the sale, lease, or disposition of VPI's assets;
•  Direct VPI's business operations, including the decision to pursue or decline government contracts;
•  Approve the entry into, amendment, or termination of material contracts;
•  Authorize the reorganization, merger, dissolution, or liquidation of VPI; and
•  Make all other material business decisions affecting VPI.
There is no minority investor, governance arrangement, or other structural feature of the post-closing ownership that would dilute or limit HSAG's control over VPI. HSAG will exercise plenary control over VPI following the closing.
Conclusion: The acquisition of 100% of VPI's equity by Halcyon US Holdings Inc. (a wholly owned subsidiary of HSAG) constitutes the acquisition of "control" of VPI within the meaning of 31 C.F.R. § 800.208. This element of the covered transaction analysis is clearly satisfied.
D. Conclusion: Covered Transaction Under § 800.213
Based on the analysis set forth in Sections IV.A through IV.C above, the proposed transaction constitutes a "covered transaction" under 31 C.F.R. § 800.213(a)(1). Specifically:
•  VPI is a "U.S. business" under § 800.252 (Section IV.A);
•  HSAG (and its wholly owned subsidiary, Halcyon US Holdings Inc.) is a "foreign person" under § 800.224 (Section IV.B); and
•  The transaction would result in HSAG/Halcyon US Holdings acquiring "control" of VPI under § 800.208 (Section IV.C).
A transaction by or with a foreign person that could result in foreign control of any U.S. business is a "covered transaction" under § 800.213(a)(1). All three elements are present here.
We have reviewed the exemptions set forth in § 800.213(d) and have determined that no exemption applies to the proposed transaction. In particular:
•  The transaction is not a stock split or pro rata stock dividend that does not involve a change in foreign ownership (§ 800.213(d)(1));
•  The transaction does not solely involve an investment in a U.S. business by a foreign person where the foreign person receives no rights beyond standard minority shareholder protections (the "passive investment" exception) — HSAG is acquiring 100% of VPI's equity (§ 800.213(d)(2));
•  The transaction is not solely an acquisition of securities by a bank acting in a fiduciary capacity (§ 800.213(d)(4)); and
•  No other exemption is applicable.
The proposed acquisition of 100% of VPI's equity by HSAG (through Halcyon US Holdings Inc.) is a covered transaction subject to CFIUS review under 31 C.F.R. § 800.213(a)(1).
V. Analysis — TID U.S. Business and Critical Technologies
Having established that the proposed transaction is a covered transaction under § 800.213, we now turn to the question of whether VPI qualifies as a "TID U.S. business" — a determination that is critical because it triggers the mandatory filing obligation under § 800.401. As explained below, VPI's status as a TID U.S. business is clear and unambiguous.
A. "TID U.S. Business" Framework (31 C.F.R. § 800.248)
Under 31 C.F.R. § 800.248, a "TID U.S. business" is a U.S. business that:
(i) Produces, designs, tests, manufactures, fabricates, or develops one or more "critical technologies" (as defined in § 800.215);
(ii) Performs certain specified functions with respect to covered investment "critical infrastructure" (as identified in column 2 of Appendix A to Part 800); or
(iii) Maintains or collects, directly or indirectly, "sensitive personal data" of U.S. citizens, as defined in § 800.241.
Our analysis focuses primarily on prong (i) — critical technologies — as the principal basis for VPI's TID status. As demonstrated below, VPI designs, manufactures, fabricates, and develops multiple categories of items that qualify as "critical technologies" under § 800.215. This analysis alone is sufficient to establish VPI's status as a TID U.S. business.
We also provide a supplementary analysis of prong (ii) — critical infrastructure — given VPI's role as a supplier of mission-critical semiconductor components for defense radar, missile defense, and satellite communications systems that are integral to the U.S. national defense infrastructure. While prong (i) is independently dispositive, VPI's critical infrastructure nexus further reinforces the national security sensitivity of the transaction and will be a focus of CFIUS's substantive risk assessment.
We do not believe that prong (iii) — sensitive personal data — is independently applicable to VPI. Although VPI maintains personnel records for its employees, including employees with security clearances, we have not identified evidence that VPI collects or maintains the categories of sensitive personal data of U.S. citizens specified in § 800.241 in the scope and manner contemplated by the Regulations (e.g., genetic data, financial data of more than one million individuals, or precise geolocation data).
B. VPI's Status as a Producer of "Critical Technologies" (31 C.F.R. § 800.215)
1. Definition of Critical Technologies
Under 31 C.F.R. § 800.215, "critical technologies" include the following categories of items:
(a) Defense articles or defense services included on the United States Munitions List ("USML") set forth in the International Traffic in Arms Regulations ("ITAR") at 22 C.F.R. Parts 120–130, as administered by the Department of State's Directorate of Defense Trade Controls ("DDTC");
(b) Items included on the Commerce Control List ("CCL") set forth in Supplement No. 1 to Part 774 of the Export Administration Regulations ("EAR"), 15 C.F.R. Parts 730–774, that are controlled pursuant to multilateral regimes (i.e., for reasons listed in Column 1 of the Commerce Country Chart at Supplement No. 1 to Part 738 of the EAR) or for reasons set forth in Column 2 of the Commerce Country Chart;
(c) Specially designed and prepared nuclear equipment, parts and components, materials, software, and technology controlled pursuant to 10 C.F.R. Part 810 or specific Nuclear Regulatory Commission regulations — not applicable to VPI;
(d) Select agents and toxins specified under 7 C.F.R. Part 331, 9 C.F.R. Part 121, or 42 C.F.R. Part 73 — not applicable to VPI; and
(e) Emerging and foundational technologies controlled pursuant to Section 1758 of the Export Control Reform Act of 2018 ("ECRA"), 50 U.S.C. § 4817 — potentially applicable to VPI's advanced GaN semiconductor technology, although to date the Department of Commerce has not issued controls under Section 1758 that would specifically encompass VPI's product lines.
As detailed below, VPI produces items that fall squarely within categories (a) and (b) above. Both categories independently qualify VPI as a producer of "critical technologies" under § 800.215.
2. VPI Products Qualifying as ITAR-Controlled Defense Articles
VPI designs and manufactures GaN (gallium nitride) power amplifier chips, modules, and integrated assemblies used in defense radar systems, missile defense applications, and military satellite communications systems. A significant portion of VPI's product portfolio constitutes defense articles subject to the jurisdiction of the ITAR and classified under the United States Munitions List.
ITAR Registration. VPI has been registered with the Directorate of Defense Trade Controls ("DDTC") since 2011. VPI's DDTC Registration Number is M-24817. Under 22 C.F.R. § 122.1, any person who engages in the business of manufacturing, exporting, or temporarily importing defense articles or furnishing defense services is required to register with DDTC. VPI's registration reflects its longstanding engagement in the manufacture of ITAR-controlled defense articles.
USML Classification. VPI's defense-related products are classified as defense articles under ITAR Category XI(a)(3) — Military Electronics. Category XI covers military electronics, including electronic equipment and components that are specifically designed, developed, configured, adapted, or modified for military applications. VPI's GaN power amplifier components are specifically designed for integration into military radar systems, missile defense platforms, and defense satellite communications systems, and are engineered to meet military specifications (e.g., MIL-STD-883, MIL-PRF-38534) that exceed commercial-grade requirements.
Specific ITAR-Controlled Products. The following VPI products are classified under ITAR Category XI(a)(3):
•  GaN HEMT (High Electron Mobility Transistor) modules for the AN/TPS-80 G/ATOR (Ground/Air Task-Oriented Radar) system — a multifunction active electronically scanned array (AESA) radar system developed for the U.S. Marine Corps and U.S. Army. VPI supplies GaN HEMT power amplifier modules that are integral to the radar's transmit/receive (T/R) modules.
•  GaN-based T/R (Transmit/Receive) modules for missile defense systems developed under contract with the Missile Defense Agency ("MDA"). These T/R modules are designed for integration into ground-based and ship-based missile defense radar systems and are classified as defense articles under Category XI.
•  Next-generation mmWave (millimeter-wave) power amplifiers developed under contract with the U.S. Air Force Research Laboratory ("AFRL"). These advanced power amplifiers are designed for military satellite communications and electronic warfare applications, operating at frequencies above 30 GHz, and are classified as defense articles due to their specific military design and application.
Export Authorizations. VPI holds three (3) active DSP-5 export licenses issued by DDTC authorizing the export of ITAR-controlled defense articles to NATO allies, specifically the United Kingdom and Australia. The existence of these licenses confirms DDTC's jurisdiction over VPI's products and their classification as defense articles under the USML.
Critical Technology Determination. Items classified under the United States Munitions List are per se "critical technologies" under 31 C.F.R. § 800.215(a). VPI's ITAR Category XI(a)(3) defense articles therefore satisfy the "critical technology" definition without further analysis of export licensing requirements or Commerce Country Chart designations.
3. VPI Products Qualifying as EAR-Controlled Dual-Use Items
In addition to its ITAR-controlled defense articles, VPI produces a portfolio of commercial and dual-use semiconductor products that are subject to the Export Administration Regulations and classified under specific Export Control Classification Numbers ("ECCNs") on the Commerce Control List ("CCL"). The following ECCNs are applicable to VPI's products:
ECCN 3A001 — Electronic Components (Semiconductors).
VPI manufactures GaN power amplifier components used in commercial 5G telecommunications infrastructure and dual-use satellite communications applications. These components are classified under ECCN 3A001, which covers "electronic components" including certain categories of semiconductors, integrated circuits, and microwave/millimeter-wave devices. Items classified under ECCN 3A001 are controlled for National Security (NS) and Anti-Terrorism (AT) reasons.
VPI's ECCN 3A001 items include GaN-on-SiC monolithic microwave integrated circuits (MMICs) with output power densities and frequency ranges that meet or exceed the control parameters specified in ECCN 3A001.b.2 (microwave transistors) and 3A001.b.3 (microwave solid-state amplifiers). These items are designed and manufactured at VPI's Albuquerque fabrication facility using VPI's proprietary GaN-on-SiC epitaxial growth process.
ECCN 3A991 — Other Electronic Components.
Certain of VPI's lower-specification commercial GaN components are classified under ECCN 3A991, which covers electronic components not controlled by ECCN 3A001 but subject to Anti-Terrorism (AT) controls. While ECCN 3A991 items are subject to less restrictive export controls than ECCN 3A001 items, they remain controlled items on the CCL and are relevant to the comprehensive export control profile of VPI's business.
ECCN 3E001 — Technology for Development or Production of 3A001 Items.
VPI's proprietary design methodologies, process recipes, and technical data for the development and production of items controlled under ECCN 3A001 are classified under ECCN 3E001. This ECCN covers "technology" (as defined in Part 772 of the EAR) required for the "development" or "production" of items controlled by ECCNs in the 3A series. ECCN 3E001 items are controlled for National Security (NS) and Missile Technology (MT) reasons.
VPI's ECCN 3E001-controlled technology includes, but is not limited to:
•  Proprietary GaN-on-SiC epitaxial growth recipes and process parameters;
•  HEMT gate structure design data and optimization methodologies;
•  mmWave broadband matching network design files;
•  Die-level reliability screening processes and associated technical data;
•  Manufacturing process specifications for its Albuquerque fabrication facility.
Commerce Country Chart Analysis. Under 31 C.F.R. § 800.215(b), items on the CCL qualify as "critical technologies" if they are controlled for reasons specified in Column 1 or Column 2 of the Commerce Country Chart (Supplement No. 1 to Part 738 of the EAR). Items classified under ECCN 3A001 are controlled for National Security (NS) reasons, and items classified under ECCN 3E001 are controlled for both National Security (NS) and Missile Technology (MT) reasons. Both NS and MT are control reasons specified in the Commerce Country Chart, and both are among the reasons that qualify items as "critical technologies" under § 800.215(b).
With respect to the mandatory filing analysis under § 800.401(c)(2), it is necessary to determine whether a U.S. regulatory authorization would be required for the export, reexport, or transfer (in-country) of the critical technology to the principal place of business of the foreign acquiror. Germany is classified in Country Group A:1 (Wassenaar Arrangement participating states) and is a NATO ally. For many ECCN 3A001 items, License Exception STA (Strategic Trade Authorization, 15 C.F.R. § 740.20) may be available for exports to Country Group A:1 destinations, potentially eliminating the license requirement for certain of VPI's dual-use products when exported to Germany.
However, this analysis is superseded for purposes of the mandatory filing determination by the fact that VPI also produces ITAR-controlled defense articles under Category XI(a)(3). Under the ITAR, export of defense articles to any foreign person requires prior DDTC authorization (typically in the form of a DSP-5 license), regardless of the destination country. The ITAR applies without regard to the Commerce Country Chart or Country Group classifications — even exports to NATO allies require a license or an applicable exemption under 22 C.F.R. § 126.1. Accordingly, a "U.S. regulatory authorization" would indisputably be required for the export of VPI's critical technologies to HSAG (a German entity), satisfying the second prong of the mandatory filing test under § 800.401(c)(2).
Even setting aside the ITAR analysis, the EAR analysis independently supports the mandatory filing determination for the following reasons: while License Exception STA may be available for certain ECCN 3A001 items exported to Germany (Country Group A:1), this availability is not universal. Certain subcategories of ECCN 3A001 items — particularly those with parameters that fall within the scope of Missile Technology Control Regime (MTCR) Annex items — may not be eligible for STA. Moreover, the determination of STA eligibility is fact-specific and depends on the particular technical parameters of the items in question, the end-use, and the end-user. For ECCN 3E001 technology controlled for MT reasons, License Exception STA is generally not available. Given the complexity of these determinations and the interplay between ITAR and EAR controls, the most conservative and defensible conclusion is that a U.S. regulatory authorization would be required for the export of VPI's critical technologies to the foreign acquiror.
4. Conclusion on Critical Technology Status
VPI is unambiguously a TID U.S. business engaged in the production, design, manufacture, and development of "critical technologies" as defined in 31 C.F.R. § 800.215. Specifically:
(a) ITAR Category XI(a)(3) defense articles — VPI designs and manufactures GaN power amplifier components classified as defense articles under Category XI(a)(3) of the United States Munitions List. These items are "critical technologies" under § 800.215(a).
(b) EAR ECCN 3A001 and ECCN 3E001 controlled items — VPI produces dual-use semiconductor components classified under ECCN 3A001 (controlled for NS and AT reasons) and maintains proprietary technology classified under ECCN 3E001 (controlled for NS and MT reasons). These items are "critical technologies" under § 800.215(b).
Each of these categories independently satisfies the "critical technology" prong of the TID U.S. business definition under § 800.248(a). Taken together, they present an overwhelming case for VPI's classification as a TID U.S. business.
C. Critical Infrastructure Considerations
While the critical technology analysis in Section V.B above is independently sufficient to establish VPI's TID status and trigger the mandatory filing obligation, VPI's role in the defense industrial base further underscores the national security sensitivity of the proposed transaction. We briefly address VPI's critical infrastructure nexus below, as it is relevant to CFIUS's substantive risk assessment even if it is not strictly necessary for jurisdictional purposes.
VPI's Albuquerque fabrication facility (CAGE Code 7VK92) is part of the U.S. defense industrial base. VPI is one of a limited number of domestic producers of GaN-on-SiC power amplifier components with the capabilities, security clearances, and government contract relationships necessary to serve as a supplier of mission-critical semiconductor components for the following defense systems and programs:
•  Active electronically scanned array (AESA) radar systems — VPI supplies GaN HEMT power amplifier modules for the AN/TPS-80 G/ATOR radar system and other AESA radar platforms.
•  Missile defense systems — VPI supplies GaN-based T/R modules for ground-based and sea-based missile defense radar systems under contract with the Missile Defense Agency.
•  Military satellite communications — VPI develops advanced mmWave power amplifiers for next-generation military SATCOM systems under contract with the U.S. Air Force Research Laboratory.
•  Naval combat systems — VPI supplies components under subcontract to Ironclad Defense Systems Inc. for integration into USN NAVSEA combat systems.
•  Border surveillance systems — VPI develops RF components for border surveillance radar systems under contract with the Department of Homeland Security Science and Technology Directorate.
VPI currently maintains 14 active DoD contracts (both prime contracts and subcontracts), with an aggregate backlog of approximately $193 million. The table below summarizes VPI's top five contracts by backlog value:
VPI's position in the defense supply chain for GaN power amplifier technology is particularly significant because the domestic industrial base for this category of advanced semiconductor components is limited. The loss of VPI as a cleared, ITAR-registered domestic supplier would have meaningful implications for the defense programs it supports. This is a factor that CFIUS will weigh heavily in its national security risk assessment, and it increases the likelihood that CFIUS will require significant mitigation measures — including, most likely, a National Security Agreement — as a condition to clearance.
While this critical infrastructure analysis reinforces the national security sensitivity of the transaction, we emphasize that VPI's TID status is established independently through the critical technology analysis in Section V.B, and the critical infrastructure analysis is not necessary to establish CFIUS jurisdiction or the mandatory filing obligation.
VI. Analysis — Mandatory Filing Obligation
A. Mandatory Declaration Under 31 C.F.R. § 800.401
Having established that (i) the proposed transaction is a "covered transaction" under § 800.213 (Section IV), and (ii) VPI is a "TID U.S. business" that produces critical technologies under §§ 800.248 and 800.215 (Section V), we now address whether the transaction triggers the mandatory filing obligation under 31 C.F.R. § 800.401.
Section 800.401(a) requires parties to a covered transaction to submit a declaration to CFIUS at least 30 days prior to the expected completion date of the transaction where both of the following conditions are met:
(1) The U.S. business that is the subject of the transaction produces, designs, tests, manufactures, fabricates, or develops one or more "critical technologies" (as defined in § 800.215); and
(2) A U.S. regulatory authorization would be required for the export, reexport, or transfer (in-country) of such critical technology to the foreign person that is a party to the transaction, or to any person that holds a direct or indirect interest in the foreign person that is a foreign person (i.e., the foreign acquiror's relevant foreign shareholders).
Application to the Proposed Transaction:
First Condition — Critical Technology Production. As demonstrated in Section V.B above, VPI produces, designs, manufactures, fabricates, and develops critical technologies in at least two categories:
(a) ITAR Category XI(a)(3) defense articles — GaN power amplifier components for military radar, missile defense, and satellite communications systems; and
(b) EAR ECCN 3A001 and ECCN 3E001 items — dual-use GaN semiconductor components and associated production/development technology.
The first condition of § 800.401(a) is clearly satisfied.
Second Condition — U.S. Regulatory Authorization Required. A U.S. regulatory authorization would be required for the export of VPI's critical technologies to HSAG (and its relevant foreign shareholders) for the following reasons:
(a) ITAR-controlled items: VPI's ITAR Category XI(a)(3) defense articles cannot be exported to any foreign person without prior authorization from DDTC, typically in the form of a DSP-5 export license. This requirement applies regardless of the destination country. Even exports to NATO allies, including Germany, require an approved export license or the applicability of a specific ITAR exemption under 22 C.F.R. § 126.1. No blanket exemption exists for Germany. Accordingly, a U.S. regulatory authorization (DDTC export license) would be required for the export of VPI's ITAR-controlled critical technologies to HSAG, a German entity. This fact alone satisfies the second condition.
(b) EAR-controlled items: VPI's ECCN 3A001 items are controlled for National Security (NS) and Anti-Terrorism (AT) reasons. While Germany is a Country Group A:1 destination and License Exception STA (15 C.F.R. § 740.20) may be available for certain ECCN 3A001 items exported to Germany, this determination is fact-specific and may not apply to all of VPI's ECCN 3A001 items, particularly those with parameters meeting MTCR Annex thresholds. VPI's ECCN 3E001 technology, controlled for Missile Technology (MT) reasons, is generally not eligible for License Exception STA. In any event, the ITAR analysis above independently satisfies the second condition, rendering the EAR analysis supplementary.
Conclusion: The mandatory filing obligation under 31 C.F.R. § 800.401 is triggered. Both conditions of § 800.401(a) are satisfied. VPI produces critical technologies (ITAR Category XI(a)(3) defense articles and EAR ECCN 3A001/3E001 items), and a U.S. regulatory authorization (at minimum, a DDTC export license for VPI's ITAR-controlled defense articles) would be required for the export of such critical technologies to HSAG. The parties are therefore obligated to file with CFIUS before completing the transaction.
B. Filing Options: Short-Form Declaration vs. Full Voluntary Joint Notice
Under 31 C.F.R. § 800.401(a), parties may satisfy the mandatory filing requirement by submitting either:
(a) A short-form declaration under 31 C.F.R. § 800.403, which is limited to five pages (plus certain attachments) and triggers a 30-day assessment period during which CFIUS may (i) request that the parties file a full notice, (ii) initiate a unilateral review, (iii) notify the parties that CFIUS is unable to conclude action on the basis of the declaration alone, or (iv) notify the parties that CFIUS has concluded there are no unresolved national security concerns; or
(b) A full voluntary joint notice under 31 C.F.R. § 800.501, which is a comprehensive submission (typically 25–50+ pages with extensive exhibits and appendices) that triggers a 45-calendar-day review period, with the possibility of a subsequent 45-calendar-day investigation period if CFIUS determines that the transaction requires further examination.
The filing of a full voluntary joint notice is deemed to satisfy the mandatory declaration requirement. See 31 C.F.R. § 800.401(f). Accordingly, the parties may elect to file either a short-form declaration or a full notice; either approach satisfies the statutory and regulatory obligation.
Recommendation. We strongly recommend that the parties file a full voluntary joint notice under 31 C.F.R. § 800.501 rather than a short-form mandatory declaration under § 800.403. The detailed strate